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Abstract
Background Refractory tremor in tremor-dominant (TD) or
equivalent-type (EQT) idiopathic Parkinson’s syndrome
(IPS) poses the challenge of choosing the best target region
to for deep brain stimulation (DBS). While the subthalamic
nucleus is typically chosen in younger patients as the target for
dopamine-responsive motor symptoms, it is more complicat-
ed if tremor does not (fully) respond under trial conditions. In
this report, we present the first results from simultaneous bi-
lateral DBS of the DRT (dentato-rubro-thalamic tract) and the
subthalamic nucleus (STN) in two elderly patients with EQT
and TD IPS and dopamine-refractory tremor.
Methods Two patients received bilateral octopolar DBS elec-
trodes in the STN additionally traversing the DRT region.
Achieved electrode positions were determined with helical
CT, overlaid onto DTI tractography data, and compared with
clinical data of stimulation response.
Results Both patients showed immediate and sustained im-
provement of their tremor, bilaterally.
Conclusions The proposed approach appears to be safe and
feasible and a combined stimulation of the two target regions
was performed tailored to the patients’ symptoms. Clinically,
no neuropsychiatric effects were seen. Our pilot data suggest a
viable therapeutic option to treat the subgroup of TD and EQT
IPS and with tremor as the predominant symptom. A clinical
study to further investigate this approach (OPINION: www.
clinicaltrials.gov; NCT02288468) is the focus of our ongoing
research.
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Abbreviations
cZI Caudal zona incerta
CT Computed tomography
DBS Deep brain stimulation
DRT Dentato-rubro-thalamic tract




IPS Idiopathic Parkinson syndrome
LED L-dopa equivalent dose
MCP Mid-commissural point
MRI Magnetic resonance imaging
PD Parkinson’s disease
pSTR Posterior subthalamic region
TD Tremor-dominant
Vim Ventral intermediate nucleus of thalamus
Introduction
Tremor is the most salient motor symptom of Parkinson’s
disease (IPS = idiopathic Parkinson syndrome) and other
symptoms are bradykinesia, rigidity, and postural instability.
Up to 75 % of patients show resting tremor [16]. Initially,
tremor is typically unilateral and only visible in stressful
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situations. In the later stage of the disease, it becomes bilateral.
Patients might in later stages show a postural and/or kinetic
tremor as well, usually with the same tremor frequency [8].
Besides fluctuations, therapy refractory tremor is one of the
main indications of DBS [12], which has become a standard
treatment for the advanced stages [9, 25].
First studies have shown that thalamic DBS, which targets
the ventral intermediate nucleus of thalamus (Vim), can effec-
tively (95 %) reduce tremor in IPS. In larger cohorts, this
number was somewhat reduced to 85 % favorable outcome
[17, 20]. We have recently provided evidence that a fiber
structure (DRT = dentate-rubro-thalamic tract) that traverses
the thalamic (Vim) region might be the true target of thalamic
DBS. This structure can directly be targeted with special
tractography DTI MRI (magnetic resonance imaging) se-
quences [3] and allows for a perturbation of the tremor-
reducing network also in the subthalamic region.
While tremor can be effectively controlled over years, bra-
dykinesia and rigidity might not be well controlled under tha-
lamic DBS and additional medication [20]. In turn the use of
subthalamic nucleus (STN) DBS in a typically younger pop-
ulation shows effects on the other symptoms of IPS [23] but
has no such dramatic and instantaneous tremor reducing ef-
fects as thalamic DBS [14], especially if tremor is not a
dopamine-responsive symptom. There are anecdotal reports
on the inferiority of pure STN DBS for tremor reduction with
the need to additionally stimulate the thalamic region.
Publications on this issue are lacking, however almost every
group treating movement disorders knows such patients.
Although older patients who suffer from tremor-dominant
IPS are less likely to develop motor fluctuations, they might
at a later stage of the disease suffer from insufficient symptom
control of the other dopaminergic symptoms and these pa-
tients would potentially benefit from additional subthalamic
surgery [11, 19]. However, because of the higher neuropsy-
chiatric complication rate due to stimulation of the STN in this
patient group [25], STN DBS is typically not recommended
[11, 19].
Taking these points into account, an interesting consider-
ation might be an earlier and one-pass thalamic and subtha-
lamic implantation of DBS electrodes and a combined and
tailored deep brain stimulation strategy for both target regions
(STN and DRT), which can be adjusted according to the indi-
vidual patient’s symptoms over the course of the disease (cf.
Fig. 1). The presented work aims at the presentation of this
concept for TD IPS or patients with EQT IPS who perceive
tremor to be their dominant symptom.
Materials and methods
We report on two cases of patients with IPS who had tremor as
their predominant symptom. They were determined as therapy
refractory and selected according to consensus guidelines as
reported in the literature for DBS surgery [9, 11, 12].
Ethics All procedures performed in studies involving human
participants were in accordance with the ethical standards of
the institutional and/or national research committee and with
the 1964 Helsinki Declaration and its later amendments or
comparable ethical standards. Informed consent was obtained
from all individual participants included in the study. Since the
trajectory that is used to reach the STN is not part of the
approval process (CE mark) for the DBS device, the approach
is left to the discretion of the surgeon. In order to allow for a
co-stimulation of two tremor targets (STN and DRT), we
chose for a parietal image-assisted approach. The combined
stimulation can be regarded as Bcompassionate use^. The pre-
sentation of DTI fiber tractographic results together with clin-
ical results received Freiburg University institutional review
board approval (No. 567/14).
Imaging
Anatomical and diffusion tensor imaging was performed on a
clinical 3-Tesla MRI system (Siemens Magnetom Trio Tim
System 3T, Erlangen, Germany) a day before surgery under
mild sedation with oral Lorazepam (1–2.5 mg, Pfizer, Berlin,
Germany). Anatomical sequences: 12-channel head coil, 3D
MPRAGE (Magnetisation Prepared Rapid Gradient Echo):
TR 1 390 ms, TE 2.15 ms, TI 800 ms, flip angle 15°, voxel
size 1.0 × 1.0 × 1.0 mm3, acquisition time 3:15. 3D T2
SPACE-sequence: TR 2 500 ms, TE 231 ms, echo train length
141, flip angle variable, voxel size 1.0×1.0×1.0 mm3, acqui-
sition time 6:42. Diffusion tensor imaging: single shot 2D SE
EPI, TR 10,000 ms, TE 94 ms, diffusion values b=0 s/mm2,
b=1000 s/mm2, diffusions directions 61, slice count 69, voxel
size 2.0 × 2.0 × 2.0 mm3, acquis i t ion t ime 11:40.
Deformation correction of the EPI sequence according to
Zaitsev et al. 2004 [26].
Fiber tracking Deterministic FT was performed on a Linux
workstation using StealthViz DTI (Medtronic Navigation,
Louisville, CO, USA). An internal transfer procedure was
used to fuse the line-graphic depiction of the DRT to the
DICOM image that further serves for navigation purposes.
With this procedure, the DRT becomes part of the stereotactic
planning data. Our group has described before fiber tracking
of the cerebello-thalamo-cortical network (DRT) and sur-
rounding structures (CST, ml) [1–4].
Surgical procedure
After administration of standard antibiotic prophylaxis, a ste-
reotactic frame (Leksell, Elekta, Stockholm, Sweden) was
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placed under local anesthesia. A CT scan was performed and
the image data were transferred to the planning workstation
(Framelink 5.0, Medtronic SNT, Louisville, CO). The previ-
ously acquired MRI sequences and the DTI FT rendition of
the DRT (as part of the stereotactic DICOM data) were co-
registered with the stereotactic CT scan and the trajectories
were planned taking into account MCP (mid-commissural
point) coordinates (for STN we typically use: x=12; y –2,
z= –4) and imaging of the targeted structures (DRT and
STN). Where necessary, based on the imaging, the target
was refined based on the direct visualization of the structures.
The bilateral DBS electrode implantation was performed
under local anesthesia with the patient in a semi-sitting posi-
tion. Using a micro-targeting drive (MicroTargeting Star
Drive M/E System, FHC Inc., Bowdoin, ME) a single test
electrode (Cosman Medical, Inc., Burlington, MA, 1.3-mm
diameter, 2-mm exposed tip) was inserted through a parietal
burr hole in the cranium. Because of anticipated
transventricular routes we elected not to use sharp microelec-
trodes for micro-recording (MER) but instead relied on the
imaging taking into account that the anterior, lateral and supe-
rior STN (= sensorimotor or dorsolateral STN) must be
targeted [6]. Macro-stimulation was performed to confirm a
contralateral clinical benefit (tremor reduction at a low thresh-
old for DRT, additional reduction of bradykinesia and rigidity
more distally on the trajectory, in the STN) and to test for side
effects (at a high threshold) in 2-mm steps starting 4 mm
above the individual target regions. In the two cases presented
here, no change of trajectories was necessary based on the
intraoperative stimulation results. The definitive DBS elec-
trodes (octopolar electrode, Boston Scientific, Natick, MA,
USA) were then implanted under lateral X-ray control. An
implantable pulse generator (Vercise™, Boston Scientific,
Natick, MA) was implanted under general anesthesia in the
sub-clavicular region during the same procedure.
Postoperatively, the patients underwent helical 3D CT scans
to corroborate the final DBS electrode locations (cf. Figs. 2, 3,
and 4).
Clinical evaluation
Clinical response of motor symptoms was evaluated using the
Unified Parkinson’s Disease Rating Scale (UPDRS), part III
(motor examinations). UPDRS scores were measured after
combined STN and DRT stimulation in Med ON, Stim ON,
and compared to preoperative Med ON. For tremor, the
Fig. 1 Graphic depiction of the DRT topography. The newly proposed
(a) approach and the traditional approach (b) to the subthalamic nucleus
(STN) with DRT (1) and STN (2) stimulation sites. Inset concept of the
use of the octopolar electrode with STN stimulation at the tip (contacts 1–
4) and DRT stimulation at the more proximal contacts (5–8). AC anterior
commissure, PC posterior commissure, MCP mid-commissural point,
MC primary motor cortex, m1, CST cortico-spinal tract, STP superior
thalamic peduncle, DRT dentato-rubro-thalamic tract, thal thalamus, CI
internal capsule, Vim ventral intermediate nucleus of thalamus stereotactic
target (possibly this is the Vop ventralis oralis posterior nucleus), ml
medial lemniscus, pSTR posterior subthalamic region, STN subthalamic
nucleus, cZI caudal zona incerta, RN red nucleus, SNr substantia nigra,
SCP superior cerebellar peduncle, DN entate nucleus
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UPDRS items related to this symptom were calculated sepa-
rately. In order to assess changes in medication, the L-dopa
equivalent doses (LED) were calculated as suggested in the
literature [24].
Fig. 2 Case no. 1, three-
dimensional rendition. Left
column (a, b): Initial implantation
attempt with traditional approach
to the STN which did not
sufficiently alleviate right upper
extremity tremor. DBS electrode
tip barely touches the DRT,
bilaterally. Right column (c, d):
Second implantation over the here
proposed parietal approach. Note
how one-pass DBS reaches the
STN and the DRT,
simultaneously. This second
approach led to satisfactory
tremor control. DRT dentato-
rubro-thalamic tract, STN
subthalamic nucleus (blue), DBS
deep brain stimulation electrode
(octopolar)
Fig. 3 Case no. 1, continued. Left
column (a, b): Initial implantation
attempt without sufficient
reduction of upper extremity
tremor. DBS electrodes (white
arrows) barely touch the DRT,
bilaterally. Right column (c, d):
Newly proposed parietal
approach. DBS electrodes
traverse the DRT, bilaterally.
ACPC parallel axial views. Z
indicates vertical coordinate.
Negative z indicates millimeters
below ACPC place.DRT dentato-
rubro-thalamic tract, CST cortico-
spinal tract, RN red nucleus, STN
subthalamic nucleus (blue); white
arrows (circles) indicate deep
brain stimulation electrode
contacts
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Results
Evaluation of tractography studies The DRT could be re-
constructed and visualized in every case as well as the
corticospinal tracts (CST) and the medial lemnisci (ml).
The fusion of the postoperative helical CT scans to the
planning data in combination with tractography results
(StealthViz DTI, Medtronic, USA) proved involvement
of the DRT and the STN in both cases (cf. Figs. 2, 3,
and 4). The anatomical sites with respect to effective con-
tacts (EC) based on the DTI and CT superimposition were
identified in both patients. Postoperatively (at day 3), a
monopolar review was performed looking for the thresh-
old for beneficial effects and side effects (typically capsu-
lar effects or paraesthesias from medial lemiscus). A clear
distinction between ECs in the STN (reducing rigidity,
bradykinesia, and tremor) and contacts located in the
DRT (reducing tremor) could be made based on the stim-
ulation results and were congruent with the imaging
evaluation.
Stimulation parameters
Detailed stimulation parameters are given in Table 2.
Patient 1 reacted over time with some speech alterations
(dysarthria; cerebellar, not capsular) elicited clinically
from his left DRT program (cf. Table 2, EC5). A reduc-
tion of pulse width to 30 µs alleviated this immediately,
something that is known from STN DBS [21]. After a
brief period of dyskinesia (leg) in patient one, contacts
were changed and a more proximal contact was stimulated
for DRT (EC4 - >EC5). Because patient 2 reacted with a
brief period of right lower extremity dyskinesias during
activation of the tip of her left electrode (STN), we
elected to switch this contact off. She is momentarily
not stimulated in her left STN but obviously would react
with anti-bradykinetic effects.
Clinical results
Clinical results are summarized in Table 1. Patients tolerated
surgery well and no worsening of the neurostatus, no infec-
tions, and no intracranial hemorrhages were seen. In both
patients, DRT and STN were reached in one-pass bilaterally
(cf. Figs. 2, 3, and 4). Combined DRT/STN-DBS reduced
global UPDRS III scores as compared to preoperative medi-
cation ON condition. Furthermore, stimulation of both target
regions at once was able to significantly alleviate tremor in
both cases (tremor items of UPDRS reduced by 78 and 75 %,
respectively). Patient 1 reported superior tremor control (es-
pecially over his right upper extremity) when compared to the
situation under traditional STN DBS. Despite some dyskine-
sias (STN) in both patients during the titration phase, and
some transient dysarthria in patient 1, no side effects were
seen. We did especially not detect any clinical signs of neuro-
psychiatric effects although we did not specifically test for
this. However, the patients’ spouses confirmed our clinical
impression.
Case reports
Case no. 1 This 75-year-old male suffers from EQT IPS di-
agnosed 12 years ago. In recent years, he experienced signif-
icant fluctuations of his therapy with an insufficient control of
his right-sided resting and some postural tremor under medi-
cation (pramipexole, rasagilin, L-dopa). During neurological
evaluation, no contraindication for DBS could be identified.
He was classified as treatment-resistant. The L-dopa challenge
test showed an improvement of 54 % on the UPDRS motor
score (63 OFF, 29 ON). His tremor reacted somewhat less
with only 12 % (16 OFF, 14 ON in the tremor items of
UPDRS III). Despite this low response of his tremor to dopa-
mine and because of his mild fluctuations with some dyskine-
sias over the days, he was selected for STN surgery, which at
this moment appeared advisable. STN DBS was successfully
Fig. 4 Case no. 2. a Three-
dimensional rendition after one-
pass implantation. DBS electrode
reaches the STN with its tip after
traversing the DRT. b Quasi-
sagittal reconstruction along right
electrode traversing the posterior
horn of the lateral ventricle. CST
cortico-spinal tract, STN
subthalamic nucleus, SNr
substantia nigra, ml medial
lemniscus, DRT dentato-rubro-
thalamic tract
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performed in a standard anterior approach (cf. Figs. 2a, b and
3a, b). All symptoms improved; however he was not quite
satisfied with the overall reduction of the right upper extremity
tremor, which posed a problem under different stimulation
patterns. This was despite a later proven relative proximity
of the electrode to the DRT, bilaterally (cf. Figs. 2 and 3).
Two months after implantation, an infection occurred and
the complete system was removed. In light of the insufficient
tremor control, he was offered the parietal approach in order to
also improve this symptom. He remained under medication
for 6 weeks and a new DBS system was implanted over the
parietal fiber tractography approach (newly described here,
Figs. 2c, d and 3c–e). After initiation of stimulation (cf.
Table 2) and a titration phase, a much better symptom control
was achieved (cf. Table 1) including satisfactory tremor con-
trol (global UPDRS III 62% improvement, tremor items 78%
improvement) and improved sleeping. The patient showed a
reduction in dopamine medication (LED: preop 665 mg,
postop 200 mg; 70 % reduced). The follow-up time was
5 months.
Case no. 2 This 76-year-old woman was diagnosed with EQT
IPS 15 years ago. Over the years, the disease progressed into
TD IPSwith somemild fluctuations and amorning right lower
extremity dystonia. The predominant symptom was right-
sided (upper and lower extremity) resting tremor, although at
the time of indication for surgery resting tremor at all extrem-
ities was present (5 Hz).
TheL-dopa challenge test showed an improvement of glob-
ally 26% (56 ON, 41 OFF) and only 12% (12 ON; 8 OFF) for
the tremor items of the UPDRS III. The patient was deter-
mined as treatment-resistant and surgery was offered.
Surgery was performed uneventfully. Under stimulation, her
symptoms markedly improved, and especially the tremor was
almost immediately alleviated. UPDRS III was reduced to 11,
globally (73 % improved) and 2, for the tremor items (75 %
improved). A marked reduction of the medication followed
during the titration phase of stimulation (cf. Table 2; LED:
preop 716mg; postop 250mg; 65% reduced). Follow-up time
was 8 months.
Discussion
Surgery of the STN utilizing a parietal approach
Anatomically, the Vim/DRT as the usual target region for
tremor typically lies more superficially and posteriorly (with
respect to the MCP reference system) than the STN target
region [3] (cf. Fig. 1). Therefore, a parietal approach is re-
quired in order to allow traversing (and later modulating) both
regions at the same time or differentially. In the typical ap-
proach to the STN region anteriorly, the antero-lateral and
superior STN is targeted [6]. In this traditional approach, the
Vim/DRT region is likely missed anteriorly, since it is located
more superficial and posterior. If the traditional approach is
used, this region can only occasionally be reached via an elec-
tric field that spreads in to this region posteriorly (cf. Fig. 3a,
b). Typically, the target for tremor surgery (Vim/DRT) is
approached by a separate trajectory anteriorly [3] that will not
or only occasionally end in the posterior STN region (pSTR, cf.
Fig. 1). However, our simulation studies showed that it could be
safely reached on the way to the STN posteriorly. In order to
achieve an optimal placement for tremor reduction, it appears
that the STN region can be skewered posteriorly, while travers-
ing the DRT in the thalamic region over this parietal route (cf.
Figs. 1a; 2c, d; 3c–e). The posterior (parietal) approach can be
used to reach the thalamic and the STN region at the same time
over one single brain-perforating path. This approach has until
today anecdotally been reported as a salvage strategy pathway to
reach the STN if in the frontal region an infection has occurred
(similar to our case 1) [27]. Our approach here is an evolution
from this first description in a different patient group namely TD
IPS. For targeting purposes, the STN is directly visualized on
T2-weighted MRI sequences. We additionally utilize the DTI
FT technology that we already use routinely in daily clinical
practice to visualize the DRT [2–4, 7]. Planning this approach
might be demanding, since a three-point trajectory (STN, DRT,
entry point) has to be found that safely enters into the target
region. However, two of the points are directly visualized with
the MRI technology and there will typically be some room to
move in the cortical entry zone. More medial approaches will
penetrate the ventricles (like in case 2, here, cf. Fig. 4).
Table 1 Patient characteristics











gl tr gl tr gl tr gl tr gl tr
1 m / 75 TD IPS 63 16 29 14 54 12* 11 3 62 78 5
2 f / 76 TD IPS 56 11 41 8 26 27* 11 2 73 75 8
Dx diagnosis, TD IPS tremor-dominant idiopathic Parkinson syndrome, UPDRS III motor part of the Unified Parkinson’s Disease Rating Scale, gl
global, tr tremor related, * lack of dopamine effect on tremor reduction
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More lateral approaches might have the danger of damaging
(sub-) cortical eloquent brain regions (Wernicke’s area on the left,
etc.). However, there is no literature that supports a higher bleed-
ing risk of this proposed posterior trajectory. From the regulatory
point, it is left to the surgeon’s discretion how he approaches the
STN. In our two cases, the parietal approach allowed a safe
placement of electrodes in both the STN and the DRT.
Trans-ventricular trajectories
Some authors discuss additional risks of traversing the ventri-
cle during DBS placement. There is a possible risk of reduced
placement accuracy and an increased bleeding risk form tra-
versing ependymal surfaces. Kramer and coworkers recently
showed equal accuracy and a similarly low bleeding risk when
traversing the ventricle for subthalamic DBS including the use
of MER [15]. In the SANTE trial on anterior nucleus DBS for
partial epilepsy, only trans-ventricular approaches were used.
No symptomatic bleedings (4.5 % incidental hemorrhages on
imaging) were detected in 110 cases [10]. While we are aware
of possible problems, we believe that with the methods ap-
plied (macroelectrode, 15-mm rigid tip of the DBS electrode
for accurate placement while traversing the ependymal sur-
faces; high-resolution T1WMRI to plan a safe trajectory with
respect to vascular anatomy) accurate and safe placement is
possible.
Intraoperative adjustment of trajectories based
on stimulation results
In the cases described here, a change of the trajectory was not
necessary. One could envision that an adjustment of the tra-
jectory might be a difficult task. Certainly an adjustment will
not be just a parallel tract. There are multiple restrictions from
the anatomical and functional environment. However, stimu-
lation of the DRT teaches us that the tract can be modulated at
different parts of it and will still be effective [2, 3]. In this
respect, the adjustment would look more like an idealized
Bice cone^ with a rather fixed tip in the anterior lateral and
superior STN [6] and larger adjustment possibilities in the
DRT and cortical portion of the trajectory.
Risk of simultaneous stimulation
There are patients that have electrodes located in Forel’s field
above the STNwho benefit from electrodes located there with
better tremor control than in traditional STN surgery (some
researchers actually think that the benefit of STN-DBS stems
from stimulation of the hyperdirect pathway (HDP) above the
STN in Forel’s field). This occasionally happens, if the DRT
region (because of anatomical variations) in the traditional
anterior approach is close enough to the more proximal elec-
trodes (Figs. 1b; 2a, b; 3a, b). In the approach chosen, we have
operationalized this in two cases and ensured the accessibility
of the DRT by choosing a parietal approach.
With this technique, patients with TD or EQT IPS can—
depending on their age, and because of the higher incidence of
neuropsychiatric side effects in pure STN DBS—receive STN
DBS, DRT DBS, or gradually both. This possibly could have
advantages during the course of the disease progression be-
cause of the adjustability of the therapy (STN for bradykine-
sia, rigidity, and tremor; DRT for tremor).
There are anecdotal reports of patients with pure thalamic
DBS that later received STN-DBS in a second surgery [11, 19].
There is no indication that hints towards detrimental effects of
simultaneous stimulation of both targets (DRT and STN) in
these reports. The other is also known, patients with STN-
DBS that later received thalamic DBS because of a later loss
of tremor control over the course of the disease. According to
our limited experience, the combined approach presumably
would allow for a better symptom control in TD and EQT IPS.
Interestingly, we have observed a very low but nevertheless
effective stimulation amplitude in both target regions. These
low amplitudes correspond to a dramatic clinical improve-
ment and a clear reduction of the LED. We are not quite sure
what the reason is but it might be that modulating fiber struc-
tures from another angle than usually (in the anterior ap-
proach) might prove be superior.
Limitations
We have extensively discussed the limitations of the fiber
tractography approach to DBS (anatomic rendition of fibers
with DTI, crossing and kissing fibers) and the limitations of
the deterministic DTI technology in our previous publications
[2–4, 7]. The deterministic approach is prone to a higher sub-
jectivity than other approaches (e.g., probabilistic
tractography). The extension of a fiber tract very much de-
pends on the software used and on a variety of other factors
(region of interest, algorithm, multiple tensor models, etc.) [1].
The Banatomical truth^ of a fiber tract like the DRT depends
Table 2 Stimulation parameters
Pat. no. Side STN DRT
1 lt EC2, (–), 1.0 mA, 60 µs EC5, (–), 2.0 mA, 30 µs
EC6, (+)
rt EC9, (–), 2.0 mA, 60 µs EC10, (–), 1.5 mA, 60 µs
2 lt – EC4, (–), 1.8 mA, 60 µs
EC5, (–), 1.2 mA, 60 µs
rt EC9, (–), 1.0 mA, 60 µs EC10, (–), 1.85 mA, 60 µs
EC11, (–), 1.85 mA, 60 µs
All stimulated with frequency of 130 Hz
EC effective contact (1–8 left, 1 most distal; 9–16 right, 9 most distal)
rt right, lt left, STN subthalamic nucleus, DRT dentato-rubro-thalamic
tract
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on the definition of a variety of parameters and on the imaging
data it originates from (e.g., most deterministic approaches
will not show a pontine decussation of the DRT). Moreover,
it is difficult to determine a Btrue accuracy^ of the determin-
istic approach [5, 22]. In a recent study, we found a level of
agreement to be ±2.5 mm when comparing electrophysiolog-
ical distance measurements with DTI. In our experience, how-
ever, the accuracy of the method is higher [18]. There are
examples in the literature for detrimental results of uncritical
use of deterministic tractography in conjunction with neuro-
navigation while ignoring electrophysiology [13]. However,
when cautiously applying this technology, it can be safely
used for navigation and targeting purposes [2, 3, 5, 7].
Certain limitations, primarily owing to the case study char-
acter of this report, have to be discussed: This report shows that
a one-pass threading of two target regions (STN and DRT) is
possible without obvious detrimental effects to the patients.
Tremor could more optimally be investigated with a more de-
tailed tremor rating (e.g., Fahn–Marsden Tremor rating scale)
and with blinded raters using video rating. We perform this in
our clinical study. We have shown that tremor and, to a certain
extent other IPS symptoms, can be positively influenced with
stimulation of these targets. We have, however, not differential-
ly tested the effects of singular STN or DRTstimulation via this
route. This certainly would be an interesting question. The
focus in the treatment of the two patients was the alleviation
of clinical symptoms of IPS. It would, however, have been
interesting to see to what extent dopaminergic medication
could be decreased depending on the target stimulated and if
stimulation of the STN and DRT over the parietal approach
could be considered in much younger patients with EQT IPS
that might later develop strong fluctuations. We cannot address
these questions with our results here. This and the question if a
combined stimulation of both regions is superior to stimulation
of single structures and the effect on the patients’ quality of life
is the focus of a clinical study that we have just initiated and
which is currently recruiting.
Conclusions
The proposed parietal approach threading the STN and DRT
in one pass appears to be feasible and safe. A differential
stimulation of the two target regions (DRT and STN) can be
performed with the implanted DBS system tailored to the
patients’ symptoms, within typical stimulation ranges.
Clinically, no neuropsychiatric effects were seen. Even with
a trans-ventricular approach in one patient, electrodes could be
safely and accurately placed in both target regions. We hy-
pothesize that the combined stimulation of the STN and the
DRT target could be superior with respect to the overall symp-
tom reduction as compared to the singular stimulation of one
individual target region (STN or DRT). In one patient who
was previously stimulated in the STN (with a traditional ante-
rior approach) this was certainly the case. In this respect, our
pilot data might suggest a new and viable therapeutic option to
treat the subgroup of TD and EQT IPS and with tremor as the
predominant symptom. However, if the results could be rep-
licated in a larger patient group, this work would have the
chance to change standardized treatment with DBS for the
whole patient group of TD or EQT IPS patients. A clinical
study (recruiting) to further investigate this approach in a larg-
er patient group (OPINION: www.clinicaltrials.gov;
NCT02288468) is the focus of our ongoing research.
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Comment
In this paper, the authors ingeniously develop a concept that permits to
treat two different aspects of the same disease in a single approach,
targeting two structures simultaneously with one electrode. This approach
has been described previously to target two contiguous structures (e.g.,
STN and SNr) (1), but in this case the structures are situated apart. This
approach introduces new nuances to be faced, such as the necessity im-
posed by the two points to traverse other possibly unwanted structures
(e.g., the ventricles, or cortical sulci), and the problems related to the
possible need to adjust the trajectory to fix the intraoperative findings in
any of the structures. New approaches, such as non straight electrode
trajectories, have to be developed if this procedure generalizes.
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